Christopher G Azzoli

Christopher G Azzoli

UNVERIFIED PROFILE

Are you Christopher G Azzoli?   Register this Author

Register author
Christopher G Azzoli

Christopher G Azzoli

Publications by authors named "Christopher G Azzoli"

Are you Christopher G Azzoli?   Register this Author

84Publications

2159Reads

25Profile Views

KRAS Mutation for Staging Resected Non-Small Cell Lung Cancer.

J Thorac Oncol 2019 Jul;14(7):e153-e155

Division of Oncology, The Warren Alpert Medical School of Brown University, Providence, Rhode Island.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.02.023DOI Listing
July 2019

Beyond and and gene rearrangements in non-small cell lung cancer.

Transl Lung Cancer Res 2017 Oct;6(5):550-559

Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/tlcr.2017.08.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5653525PMC
October 2017

Adjuvant Systemic Therapy and Adjuvant Radiation Therapy for Stage I to IIIA Completely Resected Non-Small-Cell Lung Cancers: American Society of Clinical Oncology/Cancer Care Ontario Clinical Practice Guideline Update.

J Clin Oncol 2017 Sep 24;35(25):2960-2974. Epub 2017 Apr 24.

Mark G. Kris and Jamie E. Chaft, Memorial Sloan Kettering Cancer Center; Harvey I. Pass, New York University Langone Medical Center, New York; Rahul Seth, Upstate Medical Center, Syracuse University, Syracuse, NY; Laurie E. Gaspar and Michael Weyant, University of Colorado School of Medicine, Aurora, CO; Erin B. Kennedy, American Society of Clinical Oncology, Alexandria, VA; Christopher G. Azzoli, Massachusetts General Hospital, Boston, MA; Steven H. Lin, MD Anderson Cancer Center; John R. Strawn, Patient Representative, Houston, TX; David R. Spigel, Sarah Cannon Cancer Center, Nashville, TN; Peter M. Ellis, Juravinski Cancer Center, Hamilton Health Sciences, Hamilton; Frances A. Shepherd, Princess Margaret Cancer Centre, University Health Network; and Yee C. Ung, Sunnybrook Regional Cancer Center, Toronto, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.4401DOI Listing
September 2017

Bilateral acute simultaneous onset anterior uveitis presumed secondary to erlotinib: A report of two cases.

Am J Ophthalmol Case Rep 2017 Jun 10;6:21-23. Epub 2016 Sep 10.

Department of Ophthalmology, New England Eye Center, Tufts Medical Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajoc.2016.09.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722177PMC
June 2017

Clinicopathologic Features of NSCLC Diagnosed During Pregnancy or the Peripartum Period in the Era of Molecular Genotyping.

J Thorac Oncol 2016 09 11;11(9):1522-8. Epub 2016 Jun 11.

Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.05.031DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002360PMC
September 2016

Adaptive Neoadjuvant Chemotherapy Guided by (18)F-FDG PET in Resectable Non-Small Cell Lung Cancers: The NEOSCAN Trial.

J Thorac Oncol 2016 Apr 25;11(4):537-44. Epub 2015 Dec 25.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Department of Medicine, Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2015.12.104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4808609PMC
April 2016

Reply to B. Jeremic et al.

J Clin Oncol 2016 Jan 16;34(2):197-8. Epub 2015 Nov 16.

Massachusetts General Hospital, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.64.1407DOI Listing
January 2016

Practical Value of Molecular Pathology in Stage I-III Lung Cancer: Implications for the Clinical Surgeon.

Ann Surg Oncol 2015 Oct 28;22(11):3459-65. Epub 2015 Jul 28.

Thoracic Oncology Program, Massachusetts General Hospital Cancer Center, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4704-zDOI Listing
October 2015

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.

J Clin Oncol 2015 Oct 31;33(30):3488-515. Epub 2015 Aug 31.

Gregory A. Masters, Helen F. Graham Cancer Center, Newark, DE; Sarah Temin, American Society of Clinical Oncology, Alexandria; Sherman Baker Jr, Virginia Commonwealth University; David Trent, Virginia Cancer Center, Richmond, VA; Christopher G. Azzoli, Massachusetts General Hospital Cancer Center, Boston, MA; Giuseppe Giaccone, Lombardi Cancer Center, Georgetown University, Washington, DC; Julie R. Brahmer and Thomas J. Smith, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Peter M. Ellis, Juravinski Cancer Centre, Hamilton, Ontario, Canada; Ajeet Gajra, Upstate Medical University, Syracuse, NY; Nancy Rackear, Uniting Against Lung Cancer, Fort Lauderdale, FL; Joan H. Schiller, University of Texas Southwestern; David H. Johnson, University of Texas Southwestern Medical Center at Dallas, Dallas; and John R. Strawn, patient representative, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.1342DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019421PMC
October 2015

Definitive and Adjuvant Radiotherapy in Locally Advanced Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.

J Clin Oncol 2015 Jun 5;33(18):2100-5. Epub 2015 May 5.

Andrea Bezjak, Princess Margaret Cancer Center, Toronto, Ontario, Canada; Sarah Temin, American Society of Clinical Oncology, Alexandria, VA; Gregg Franklin, New Mexico Cancer Center, Albuquerque, NM; Giuseppe Giaccone, Lombardi Cancer Center, Washington, DC; Ramaswamy Govindan, Washington University, St Louis, MO; Melissa L. Johnson, Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL; Andreas Rimner, Memorial Sloan Kettering Cancer Center; Bryan J. Schneider, Weill Cornell Medical College, New York, NY; John Strawn, Patient Representative, Houston, TX; and Christopher G. Azzoli, Massachusetts General, Boston, MA.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2014.59.2360
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.2360DOI Listing
June 2015

Serum biomarkers for assessing histology and outcomes in patients with metastatic lung cancer.

Cancer Biomark 2014 ;14(4):207-14

Department of Medicine, Hematology/Oncology, Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/CBM-140399DOI Listing
April 2015

Phase II study of the GI-4000 KRAS vaccine after curative therapy in patients with stage I-III lung adenocarcinoma harboring a KRAS G12C, G12D, or G12V mutation.

Clin Lung Cancer 2014 Nov 21;15(6):405-10. Epub 2014 Jun 21.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2014.06.002DOI Listing
November 2014

Genotyping lung cancer is an investment in the future.

J Clin Oncol 2014 Nov 8;32(31):3576-7. Epub 2014 Sep 8.

Massachusetts General Hospital Cancer Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.56.6430DOI Listing
November 2014

A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage I to IIIA non-small-cell lung cancers.

J Thorac Oncol 2014 Sep;9(9):1272-7

*Memorial Sloan Kettering Cancer Center, New York, NY; †Tokyo Medical and Dental University, Tokyo, Japan; and ‡Massachusetts General Hospital Cancer Center, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000256DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133740PMC
September 2014

The prognostic impact of KRAS, its codon and amino acid specific mutations, on survival in resected stage I lung adenocarcinoma.

J Thorac Oncol 2014 Sep;9(9):1363-9

*Division of Hematology/Oncology, Department of Medicine; †Division of Thoracic Surgery; ‡Biostatistics Center; §Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston,Massachusetts; and ‖Department of Thoracic Surgery, Guangdong General Hospital, Southern Medical University, Guangdong, China.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864153068
Publisher Site
http://dx.doi.org/10.1097/JTO.0000000000000266DOI Listing
September 2014

Adjuvant therapy for a 3.9-cm adenocarcinoma of the lung.

Oncologist 2013 25;18(12):1258-61. Epub 2013 Nov 25.

Massachusetts General Hospital Cancer Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0297DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868419PMC
August 2014

Basic mechanisms of therapeutic resistance to radiation and chemotherapy in lung cancer.

Cancer J 2013 May-Jun;19(3):200-7

Department of Radiation Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e318292e4e3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668666PMC
December 2013

Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers.

Cancer Chemother Pharmacol 2013 Oct 22;72(4):931-4. Epub 2013 Aug 22.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 300 E, 66th Street, New York, NY, 10065, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2263-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3841970PMC
October 2013

Risk of hemoptysis in patients with resected squamous cell and other high-risk lung cancers treated with adjuvant bevacizumab.

Cancer Chemother Pharmacol 2013 Aug 28;72(2):453-61. Epub 2013 Jun 28.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical School, 300 East 66th Street, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2219-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653739PMC
August 2013

Distinct clinical course of EGFR-mutant resected lung cancers: results of testing of 1118 surgical specimens and effects of adjuvant gefitinib and erlotinib.

J Thorac Oncol 2012 Dec;7(12):1815-1822

Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31826bb7b2DOI Listing
December 2012

Clinical outcomes with perioperative chemotherapy in sarcomatoid carcinomas of the lung.

J Thorac Oncol 2012 Sep;7(9):1400-5

Department of Medicine, Division of Solid Tumor Oncology, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3182614856DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632635PMC
September 2012

Screening for germline EGFR T790M mutations through lung cancer genotyping.

J Thorac Oncol 2012 Jun;7(6):1049-52

Thoracic Oncology Service and Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155608641533272
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e318250ed9dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3354706PMC
June 2012

Phase II study of the multitargeted tyrosine kinase inhibitor XL647 in patients with non-small-cell lung cancer.

J Thorac Oncol 2012 May;7(5):856-65

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31824c943fDOI Listing
May 2012

2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.

J Oncol Pract 2012 Jan 29;8(1):63-6. Epub 2011 Nov 29.

Memorial Sloan-Kettering Cancer Center, New York, NY; American Society of Clinical Oncology, Alexandria, VA; and National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2011.000374DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266319PMC
January 2012

A phase 2 study of weekly albumin-bound paclitaxel (Abraxane®) given as a two-hour infusion.

Cancer Chemother Pharmacol 2011 Nov 3;68(5):1331-7. Epub 2011 Apr 3.

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, H1011, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-011-1621-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581346PMC
November 2011

Maintained sensitivity to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer recurring after adjuvant erlotinib or gefitinib.

Clin Cancer Res 2011 Oct 10;17(19):6322-8. Epub 2011 Aug 10.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-1080DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186869PMC
October 2011

A phase II trial of Salirasib in patients with lung adenocarcinomas with KRAS mutations.

J Thorac Oncol 2011 Aug;6(8):1435-7

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Cornell Medical College, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318223c099DOI Listing
August 2011

Phase I/II trial of cetuximab and erlotinib in patients with lung adenocarcinoma and acquired resistance to erlotinib.

Clin Cancer Res 2011 Apr 19;17(8):2521-7. Epub 2011 Jan 19.

Gastrointestinal and Thoracic Oncology Services, Division of Solid Tumor Oncology, Department of Medicine and Radiology, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-10-2662DOI Listing
April 2011

Impact on disease-free survival of adjuvant erlotinib or gefitinib in patients with resected lung adenocarcinomas that harbor EGFR mutations.

J Thorac Oncol 2011 Mar;6(3):569-75

Gastrointestinal Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318202bffeDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3778680PMC
March 2011

A case series of dose-limiting peripheral edema observed in patients treated with pemetrexed.

J Thorac Oncol 2011 Mar;6(3):624-6

Division of Solid Tumor Oncology, Thoracic Oncology Services, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S155608641532221
Publisher Site
http://dx.doi.org/10.1097/JTO.0b013e318207f788DOI Listing
March 2011

Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer.

J Thorac Oncol 2010 Oct;5(10):1623-9

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York City, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e3181ec1531DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4020424PMC
October 2010

A phase I trial of SJG-136 (NSC#694501) in advanced solid tumors.

Cancer Chemother Pharmacol 2010 Apr 12;65(5):833-8. Epub 2009 Aug 12.

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Avenue, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-009-1088-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3711187PMC
April 2010

American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.

J Oncol Pract 2010 Jan;6(1):39-43

Memorial Sloan-Kettering Cancer Center, New York, NY; National Cancer Institute, Bethesda, MD; and American Society of Clinical Oncology, Alexandria, VA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.091065DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2805345PMC
January 2010

Chemoradiation for unresectable stage III non-small cell lung cancer.

Semin Thorac Cardiovasc Surg 2008 ;20(3):204-9

Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.semtcvs.2008.09.007DOI Listing
March 2009

Molecularly tailored adjuvant chemotherapy for resected non-small cell lung cancer: a time for excitement and equipoise.

J Thorac Oncol 2008 Jan;3(1):84-93

Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e31815efe24DOI Listing
January 2008

Pulmonary toxicity associated with erlotinib.

Chest 2007 Sep;132(3):1042-4

Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S001236921536674
Publisher Site
http://dx.doi.org/10.1378/chest.07-0050DOI Listing
September 2007

Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer.

Cancer 2007 Aug;110(3):599-605

Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan-Kettering Cancer Center and the Weill Medical College of Cornell University, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22816DOI Listing
August 2007

A phase II tolerability study of cisplatin plus docetaxel as adjuvant chemotherapy for resected non-small cell lung cancer.

J Thorac Oncol 2007 Jul;2(7):638-44

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318074bbd0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3715043PMC
July 2007

A phase 1 study of pralatrexate in combination with paclitaxel or docetaxel in patients with advanced solid tumors.

Clin Cancer Res 2007 May;13(9):2692-8

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-1754DOI Listing
May 2007

A phase I trial of intermittent high-dose gefitinib and fixed-dose docetaxel in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2007 Mar 1;59(4):467-75. Epub 2006 Aug 1.

Division of Solid Tumor Oncology, Head and Neck Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center and Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-006-0286-6DOI Listing
March 2007

Management of patients with resectable stage IIIA (N2) NSCLC.

J Surg Oncol 2006 Dec;94(7):551-2

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.20649DOI Listing
December 2006

A phase I/II study of weekly high-dose erlotinib in previously treated patients with nonsmall cell lung cancer.

Cancer 2006 Sep;107(5):1034-41

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center and the Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.22088
Publisher Site
http://dx.doi.org/10.1002/cncr.22088DOI Listing
September 2006

A phase I clinical pharmacologic study of pralatrexate in combination with probenecid in adults with advanced solid tumors.

Cancer Chemother Pharmacol 2006 May 31;57(5):671-7. Epub 2005 Aug 31.

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-005-0080-xDOI Listing
May 2006

Randomized phase II study of weekly docetaxel plus trastuzumab versus weekly paclitaxel plus trastuzumab in patients with previously untreated advanced nonsmall cell lung carcinoma.

Cancer 2005 Nov;104(10):2149-55

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21428DOI Listing
November 2005

Can adjuvant chemotherapy improve survival in patients with early-stage, resected non-small-cell lung cancer?

Nat Clin Pract Oncol 2005 Nov;2(11):552-3

Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc0350DOI Listing
November 2005

Imatinib mesylate lacks activity in small cell lung carcinoma expressing c-kit protein: a phase II clinical trial.

Cancer 2005 May;103(10):2128-31

Thoracic Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.21000DOI Listing
May 2005

A phase I trial of perillyl alcohol in patients with advanced solid tumors.

Cancer Chemother Pharmacol 2003 Jun 15;51(6):493-8. Epub 2003 Apr 15.

Department of Medicine, Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-003-0599-7DOI Listing
June 2003

10-propargyl-10-deazaaminopterin: an antifolate with activity in patients with previously treated non-small cell lung cancer.

Clin Cancer Res 2003 Jun;9(6):2072-8

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University New York, New York 10021, USA.

View Article

Download full-text PDF

Source
June 2003

Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature.

Am J Clin Oncol 2003 Jun;26(3):247-51

Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.COC.0000017782.24458.DDDOI Listing
June 2003

Targeting lethal minimal residual disease in small cell lung cancer.

Semin Oncol 2003 Feb;30(1):79-85

Thoracic Oncology Service, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/sonc.2003.50018DOI Listing
February 2003

Trastuzumab in the treatment of non-small cell lung cancer.

Semin Oncol 2002 Feb;29(1 Suppl 4):59-65

Department of Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

View Article

Download full-text PDF

Source
February 2002